Clinical Oncology Next Generation Sequencing Market

Global Clinical Oncology Next Generation Sequencing Market Size, Trends & Analysis - Forecasts to 2028 By Application Type (Screening, Companion Diagnostics, and Other Diagnostics), By End User (Hospitals, Clinics, and Laboratories), By Technology Type (Whole Genome Sequencing, Whole Exome Sequencing, and Targeted Sequencing & Resequencing), By Workflow Type (NGS Pre-Sequencing, NGS Sequencing, and NGS Data Analysis), and By Region (North America, Asia Pacific, Central & South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

Category Healthcare
Format
  • ms word
  • ms excel
  • ms ppt
  • pdf
This report was recently updated on May 12 2024 with the latest and most recent market numbers

Global Clinical Oncology Next Generation Sequencing Market Size

The global clinical oncology next generation sequencing market is expected to grow at a CAGR of 16.4% from 2023 to 2028.

Cancer diagnostics is experiencing rapid evolution with the emergence of the clinical oncology next-generation sequencing (NGS) market. NGS enables comprehensive analysis of tumor genomes, helping clinicians to identify genetic alterations that drive cancer development and progression. This technology provides insights into individualized treatment strategies, such as targeted therapies and immunotherapies, leading to improved patient outcomes. The market is witnessing significant growth due to rising cancer incidence, advancements in sequencing technologies, and decreasing costs associated with NGS. Clinical oncology NGS offers advantages like high-throughput sequencing, simultaneous detection of multiple gene alterations, and the potential for non-invasive liquid biopsies. However, challenges remain, including data interpretation and standardization, reimbursement issues, and regulatory considerations. Overall, the clinical oncology NGS market holds immense potential to revolutionize cancer care by enabling precise and personalized treatments.

Various factors drive the clinical oncology next-generation sequencing (NGS) market. Technological advancements, increasing competition, rising healthcare spending, and the growing prevalence of cancer are key drivers. The market was influenced by the COVID-19 pandemic, which led to the implementation of regulatory guidelines and broader inclusion of NGS tests in healthcare coverage. The clinical applications of NGS in precision oncology and the ability to determine viral genetic sequences further contribute to market growth. Additionally, the rising global cancer incidence and the use of NGS in liquid biopsy and personalized medicine drive the market growth. Overall, the adoption of NGS technology, its cost-effectiveness, speed, and application in cancer research propel the clinical oncology NGS market growth.

The companies operating in the clinical oncology next-generation sequencing (NGS) market have promising prospects and ample opportunities for growth in the future. The expanding application of NGS in precision oncology presents avenues for companies to develop novel platforms and solutions for genomic insights. The rising demand for NGS in liquid biopsy offers prospects for revenue generation, enabling effective profiling and real-time monitoring of cancers. Furthermore, the increasing adoption of companion diagnostics and personalized medicine creates opportunities for companies to develop and offer NGS-based diagnostic tests and targeted therapies. Technological advancements in NGS and bioinformatics tools open doors for companies to revolutionize cancer research, diagnosis, and therapy. With the growing global prevalence of cancer, companies have the opportunity to meet the demand for accurate and efficient NGS solutions in the oncology field, driving growth and innovation in the market.

global clinical oncology next generation sequencing market

Global Clinical Oncology Next Generation Sequencing Market: By Technology Type

Based on the technology type, the market is segmented into whole genome sequencing, whole exome sequencing, and targeted sequencing & resequencing. The targeted sequencing & resequencing segment is anticipated to be the largest segment during the forecast period. This is due to its advantages, including time and cost savings and efficient detection of malignant tumours. Clinical studies have demonstrated the high clinical utility of targeted panels, making them a preferred choice in around 64% of cancer cases.

Global Clinical Oncology Next Generation Sequencing Market: By Application Type

Based on the application type, the market is segmented into screening, companion diagnostics, and other diagnostics. The screening segment is projected to be the largest segment during the forecast period. This is due to its widespread utilization in cancer screening programs globally. NGS-based testing is highly efficient in identifying genetic alterations for targeted clinical benefits, allowing simultaneous assessment of multiple gene alterations by clinicians.

Global Clinical Oncology Next Generation Sequencing Market: By Workflow Type

Based on the workflow type, the market is segmented into NGS pre-sequencing, NGS sequencing, and NGS data analysis. The NGS sequencing segment is anticipated to be the dominant segment during the forecast period, attributed to its critical role in the complete sequencing workflow. With the use of cutting-edge platforms, NGS sequencing has become essential for comprehensive analysis. The segment's growth is further fuelled by the increasing number of cancer sequencing projects, which analyse numerous tumour samples across various cancer types.

Global Clinical Oncology Next Generation Sequencing Market: By End User

Based on the end user, the market is segmented into hospitals, clinics, and laboratories. The laboratories segment is expected to be the largest segment during the forecast period. This is because of pre-existing workflows, detailed guidelines, and regulatory control. Developed laboratories have established standardized procedures, and FDA-approved tests come with specified standards and performance characteristics. Governing bodies like the CMS (Centres for Medicare and Medicaid Services) and state-level authorities ensure compliance, while organizations like ACMG, AMP, and CAP provide best practice guidelines for clinical laboratories.

asia pacific clinical oncology next generation sequencing market

Global Clinical Oncology Next Generation Sequencing Market: By Region

North America is analyzed to be the largest region in the global clinical oncology next generation sequencing market in the forecast period. This can be attributed to several factors. Regulatory bodies in the United States are implementing measures to enhance cancer screening and diagnosis, boosting the demand for NGS technologies. Additionally, the region witnesses substantial research and development investments, driving innovation and technological advancements in NGS. The combination of supportive regulatory frameworks, increased R&D investments, and the presence of leading players has contributed to North America's leadership in the clinical oncology NGS market.

Asia Pacific is also analyzed to be the fastest-growing region across the global clinical oncology next generation sequencing market. This can be attributed to several factors, including decreased sequencing costs, favourable government policies, rising investments in research and development (R&D), and competitive pricing strategies by key market players. China, in particular, has witnessed a significant decline in sequencing costs, making NGS services and products more affordable than other countries. The market growth in the APAC region is further fuelled by supportive government policies and substantial investments by key players, creating a conducive environment for expanding clinical oncology NGS technologies in the region.

Global Clinical Oncology Next Generation Sequencing Market Share and Competitor Analysis

The key players operating in the market are Illumina Inc., Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Agilent Technologies, Myriad Genetics, Perkin Elmer, Caris Life Sciences, Partek, Inc., Eurofins Scientific, and Qiagen N.V. among others.

Please note: This is not an exhaustive list of companies profiled in the report.

1          STRATEGIC INSIGHTS ON NEW REVENUE POCKETS

1.1    Strategic Opportunity & Attractiveness Analysis

1.1.1        Hot Revenue Pockets

1.1.2        Market Attractiveness Score

1.1.3        Revenue Impacting Opportunity

1.1.4        High Growing Region/Country

1.1.5        Competitor Analysis

1.1.6        Consumer Analysis

1.2    Global Market Estimates' View

1.3    Strategic Insights across Business Functions

1.3.1        For Chief Executive Officers

1.3.2        For Chief Marketing Officers

1.3.3        For Chief Strategy Officers

1.4    Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into

2          TECHNOLOGICAL TRENDS

2.1   Technological Adoption Rate

2.2   Current Trend Impact Analysis

2.3   Future Trend Impact Analysis

3          GLOBAL MARKET OUTLOOK

3.1   Market Pyramid Analysis

3.1.1        Introduction

3.1.2        Adjacent Market Opportunities

3.1.3        Ancillary Market Opportunities

3.2   Demand Side Analysis

3.2.1        Market Drivers: Impact Analysis

3.2.2        Market Restraints: Impact Analysis

3.2.3        Market Opportunities: Impact Analysis

3.2.4        Market Challenges: Impact Analysis

3.3   Supply Side Analysis

3.3.1        Porter’s Five Forces Analysis

3.3.1.1 Threat of New Entrants

3.3.1.2 Threat of New Substitutes

3.3.1.3 Bargaining Power of Suppliers

3.3.1.4 Bargaining Power of Buyers

3.3.1.5 Intensity of Competitive Rivalry

3.3.2        SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)

3.3.2.1 Political Landscape

3.3.2.2 Economic Landscape

3.3.2.3 Social Landscape

3.3.2.4 Technology Landscape

3.3.3        Value Chain Analysis

3.3.4        Trend Analysis

3.3.5        Gap Analysis

3.3.6        Cost Analysis

4          GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY TYPE

4.1   Introduction

4.2   Clinical Oncology Next Generation Sequencing Market: Technology Type Scope Key Takeaways

4.3   Revenue Growth Analysis, 2022 & 2028

4.4   Whole Genome Sequencing

4.4.1        Whole Genome Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

4.5   Whole Exome Sequencing

4.5.1        Whole Exome Sequencing Market Estimates And Forecast, 2020-2028 (USD Billion)

4.6   Targeted Sequencing & Resequencing

4.6.1        Targeted Sequencing & Resequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

5          GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY END USER

5.1   Introduction

5.2   Clinical Oncology Next Generation Sequencing Market: End User Scope Key Takeaways

5.3   Revenue Growth Analysis, 2022 & 2028

5.4   Hospitals

5.4.1        Hospitals Market Estimates and Forecast, 2020-2028 (USD Billion)

5.5   Clinics

5.5.1        Clinics Market Estimates and Forecast, 2020-2028 (USD Billion)

5.6   Laboratories

5.6.1        Laboratories Market Estimates and Forecast, 2020-2028 (USD Billion)

6         GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY APPLICATION TYPE

6.1   Introduction

6.2   Clinical Oncology Next Generation Sequencing Market: Application Type Scope Key Takeaways

6.3   Revenue Growth Analysis, 2022 & 2028

6.4   Screening

6.4.1        Screening Market Estimates and Forecast, 2020-2028 (USD Billion)

6.5   Companion Diagnostics

6.5.1        Companion Diagnostics Market Estimates and Forecast, 2020-2028 (USD Billion)

6.6   Other Diagnostics

6.6.1        Other Diagnostics Market Estimates and Forecast, 2020-2028 (USD Billion)

7         GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY WORKFLOW TYPE

7.1   Introduction

7.2   Clinical Oncology Next Generation Sequencing Market: Workflow Type Scope Key Takeaways

7.3   Revenue Growth Analysis, 2022 & 2028

7.4   NGS Pre-Sequencing

7.4.1        NGS Pre-Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

7.5   NGS Sequencing

7.5.1        NGS Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

7.6   NGS Data Analysis

7.6.1        NGS Data Analysis Market Estimates and Forecast, 2020-2028 (USD Billion)

8          GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY REGION

8.1   Introduction

8.2   North America Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.2.1        By Technology Type

8.2.2        By End User

8.2.3        By Application Type

8.2.4        By Workflow Type  

8.2.5        By Country

8.2.5.1     U.S. Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.2.5.1.1        By Technology Type

8.2.5.1.2        By End User

8.2.5.1.3        By Application Type

8.2.5.1.4        By Workflow Type

8.2.5.2     Canada Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.2.5.2.1        By Technology Type

8.2.5.2.2        By End User

8.2.5.2.3        By Application Type

8.2.5.2.4        By Workflow Type

8.2.5.3     Mexico Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.2.5.3.1        By Technology Type

8.2.5.3.2        By End User

8.2.5.3.3        By Application Type

8.2.5.3.4        By Workflow Type

8.3   Europe Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.3.1        By Technology Type

8.3.2        By End User

8.3.3        By Application Type

8.3.4        By Workflow Type  

8.3.5        By Country

8.3.5.1     Germany Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.3.5.1.1        By Technology Type

8.3.5.1.2        By End User

8.3.5.1.3        By Application Type

8.3.5.1.4        By Workflow Type

8.3.5.2     U.K. Presered Flowers Market Estimates and Forecast, 2020-2028 (USD Billion)

8.3.5.2.1        By Technology Type

8.3.5.2.2        By End User

8.3.5.2.3        By Application Type

8.3.5.2.4        By Workflow Type

8.3.5.3     France Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.3.5.3.1        By Technology Type

8.3.5.3.2        By End User

8.3.5.3.3        By Application Type

8.3.5.3.4        By Workflow Type

8.3.5.4     Italy Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.3.5.4.1        By Technology Type

8.3.5.4.2        By End User

8.3.5.4.3        By Application Type

8.3.5.4.4        By Workflow Type

8.3.5.5     Spain Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.3.5.5.1        By Technology Type

8.3.5.5.2        By End User

8.3.5.5.3        By Application Type

8.3.5.5.4        By Workflow Type

8.3.5.6     Netherlands Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.3.5.6.1        By Technology Type

8.3.5.6.2        By End User

8.3.5.6.3        By Application Type

8.3.5.6.4        By Workflow Type

8.3.5.7     Rest of Europe Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.3.5.7.1        By Technology Type

8.3.5.7.2        By End User

8.3.5.7.3        By Application Type

8.3.5.7.4        By Workflow Type

8.4   Asia Pacific Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.4.1        By Technology Type

8.4.2        By End User

8.4.3        By Application Type

8.4.4        By Workflow Type  

8.4.5        By Country

8.4.5.1     China Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.4.5.1.1        By Technology Type

8.4.5.1.2        By End User

8.4.5.1.3        By Application Type

8.4.5.1.4        By Workflow Type

8.4.5.2     Japan Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.4.5.2.1        By Technology Type

8.4.5.2.2        By End User

8.4.5.2.3        By Application Type

8.4.5.2.4        By Workflow Type

8.4.5.3     India Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.4.5.3.1        By Technology Type

8.4.5.3.2        By End User

8.4.5.3.3        By Application Type

8.4.5.3.4        By Workflow Type

8.4.5.4     South Korea Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.4.5.4.1        By Technology Type

8.4.5.4.2        By End User

8.4.5.4.3        By Application Type

8.4.5.4.4        By Workflow Type

8.4.5.5     Singapore Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.4.5.5.1        By Technology Type

8.4.5.5.2        By End User

8.4.5.5.3        By Application Type

8.4.5.5.4        By Workflow Type

8.4.5.6     Malaysia Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.4.5.6.1        By Technology Type

8.4.5.6.2        By End User

8.4.5.6.3        By Application Type

8.4.5.6.4        By Workflow Type

8.4.5.7     Thailand Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.4.5.7.1        By Technology Type

8.4.5.7.2        By End User

8.4.5.7.3        By Application Type

8.4.5.7.4        By Workflow Type

8.4.5.8     Indonesia Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.4.5.8.1        By Technology Type

8.4.5.8.2        By End User

8.4.5.8.3        By Application Type

8.4.5.8.4        By Workflow Type

8.4.5.9     Vietnam Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.4.5.9.1        By Technology Type

8.4.5.9.2        By End User

8.4.5.9.3        By Application Type

8.4.5.9.4        By Workflow Type

8.4.5.10  Taiwan Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.4.5.10.1      By Technology Type

8.4.5.10.2      By End User

8.4.5.10.3      By Application Type

8.4.5.10.4      By Workflow Type

8.4.5.11  Rest of Asia Pacific Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.4.5.11.1      By Technology Type

8.4.5.11.2      By End User

8.4.5.11.3      By Application Type

8.4.5.11.4      By Workflow Type

8.5   Middle East and Africa Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.5.1        By Technology Type

8.5.2        By End User

8.5.3        By Application Type

8.5.4        By Workflow Type  

8.5.5        By Country

8.5.5.1     Saudi Arabia Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.5.5.1.1        By Technology Type

8.5.5.1.2        By End User

8.5.5.1.3        By Application Type

8.5.5.1.4        By Workflow Type

8.5.5.2     U.A.E. Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.5.5.2.1        By Technology Type

8.5.5.2.2        By End User

8.5.5.2.3        By Application Type

8.5.5.2.4        By Workflow Type

8.5.5.3     Israel Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.5.4.3.1        By Technology Type

8.5.4.3.2        By End User

8.5.4.3.3        By Application Type

8.5.5.3.4        By Workflow Type

8.5.5.4     South Africa Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.5.5.4.1        By Technology Type

8.5.5.4.2        By End User

8.5.5.4.3        By Application Type

8.5.5.4.4        By Workflow Type

8.5.5.5     Rest of Middle East and Africa Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.5.5.5.1        By Technology Type

8.5.5.5.2        By End User

8.5.5.5.2        By Application Type

8.5.5.5.4        By Workflow Type

8.6   Central & South America Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.6.1        By Technology Type

8.6.2        By End User

8.6.3        By Application Type

8.6.4        By Workflow Type

8.6.5        By Country

8.6.5.1     Brazil Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.6.5.1.1        By Technology Type

8.6.5.1.2        By End User

8.6.5.1.3        By Application Type

8.6.5.1.4        By Workflow Type

8.6.5.2     Argentina Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.6.5.2.1        By Technology Type

8.6.5.2.2        By End User

8.6.5.2.3        By Application Type

8.6.5.2.4        By Workflow Type

8.6.5.3     Chile Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.6.5.3.1        By Technology Type

8.6.5.3.2        By End User

8.6.5.3.3        By Application Type

8.6.5.5.4        By Workflow Type

8.6.5.4     Rest of Central & South America Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)

8.6.5.4.1        By Technology Type

8.6.5.4.2        By End User

8.6.5.4.3        By Application Type

8.6.5.4.4        By Workflow Type

9          COMPETITIVE LANDCAPE

9.1   Company Market Share Analysis

9.2   Four Quadrant Positioning Matrix

9.2.1        Market Leaders

9.2.2        Market Visionaries

9.2.3        Market Challengers

9.2.4        Niche Market Players

9.3   Vendor Landscape

9.3.1        North America

9.3.2        Europe

9.3.3        Asia Pacific

9.3.4        Rest of the World

9.4   Company Profiles  

9.4.1        Illumina Inc.

9.4.1.1 Business Description & Financial Analysis

9.4.1.2 SWOT Analysis

9.4.1.3 Products & Services Offered

9.4.1.4 Strategic Alliances between Business Partners

9.4.2        Thermo Fisher Scientific

9.4.2.1 Business Description & Financial Analysis

9.4.2.2 SWOT Analysis

9.4.2.3 Products & Services Offered

9.4.2.4 Strategic Alliances between Business Partners

9.4.3        F. Hoffmann-La Roche Ltd.

9.4.3.1 Business Description & Financial Analysis

9.4.3.2 SWOT Analysis

9.4.3.3 Products & Services Offered

9.4.3.4 Strategic Alliances between Business Partners

9.4.4        Agilent Technologies

9.4.4.1 Business Description & Financial Analysis

9.4.4.2 SWOT Analysis

9.4.4.3 Products & Services Offered

9.4.4.4 Strategic Alliances between Business Partners

9.4.5        Myriad Genetics

9.4.5.1 Business Description & Financial Analysis

9.4.5.2 SWOT Analysis

9.4.5.3 Products & Services Offered

9.4.5.4 Strategic Alliances between Business Partners

9.4.6        Perkin Elmer

9.4.6.1 Business Description & Financial Analysis

9.4.6.2 SWOT Analysis

9.4.6.3 Products & Services Offered

9.4.6.4 Strategic Alliances between Business Partners

9.4.7        Caris Life Sciences

9.4.7.1 Business Description & Financial Analysis

9.4.7.2 SWOT Analysis

9.4.7.3 Products & Services Offered

9.4.8.4 Strategic Alliances between Business Partners

9.4.8        Eurofins Scientific

9.4.8.1 Business Description & Financial Analysis

9.4.8.2 SWOT Analysis

9.4.8.3 Products & Services Offered

9.4.8.4 Strategic Alliances between Business Partners

9.4.9        Qiagen

9.4.9.1 Business Description & Financial Analysis

9.4.9.2 SWOT Analysis

9.4.9.3 Products & Services Offered

9.4.9.4 Strategic Alliances between Business Partners

9.4.10      Other Companies

9.4.10.1 Business Description & Financial Analysis

9.4.10.2 SWOT Analysis

9.4.10.3 Products & Services Offered

9.4.10.4 Strategic Alliances between Business Partners

10        RESEARCH METHODOLOGY

10.1 Market Introduction

10.1.1      Market Definition

10.1.2      Market Scope & Segmentation

10.2 Information Procurement

10.2.1      Secondary Research

10.2.1.1           Purchased Databases

10.2.1.2           GMEs Internal Data Repository

10.2.1.3           Secondary Resources & Third Party Perspectives

10.2.1.4           Company Information Sources

10.2.2      Primary Research

10.2.2.1           Various Types of Respondents for Primary Interviews

10.2.2.2           Number of Interviews Conducted throughout the Research Process

10.2.2.3           Primary Stakeholders

10.2.2.4           Discussion Guide for Primary Participants

10.2.3      Expert Panels

10.2.3.1           Expert Panels Across 30+ Industry

10.2.4      Paid Local Experts

10.2.4.1           Paid Local Experts Across 30+ Industry Across each Region

10.3 Market Estimation

10.3.1      Top-Down Approach

10.3.1.1           Macro-Economic Indicators Considered

10.3.1.2           Micro-Economic Indicators Considered

10.3.2      Bottom Up Approach

10.3.2.1           Company Share Analysis Approach

10.3.2.2           Estimation of Potential Product Sales

10.4 Data Triangulation

10.4.1      Data Collection

10.4.2      Time Series, Cross Sectional & Panel Data Analysis

10.4.3      Cluster Analysis

10.5 Analysis and Output

10.5.1      Inhouse AI Based Real Time Analytics Tool

10.5.2      Output From Desk & Primary Research

10.6 Research Assumptions & Limitations

10.7.1      Research Assumptions

10.7.2      Research Limitations

LIST OF TABLES

1 Global Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)

2 Whole Genome Sequencing Market, By Region, 2020-2028 (USD Billion)  

3 WHOLE EXOME SEQUENCING Market, By Region, 2020-2028 (USD Billion)     

4 Targeted Sequencing & Resequencing Market, By Region, 2020-2028 (USD Billion)

5 Global Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)     

6 Hospitals Market, By Region, 2020-2028 (USD Billion)        

7 CLINICS Market, By Region, 2020-2028 (USD Billion)

8 Laboratories Market, By Region, 2020-2028 (USD Billion)

9 Global Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)

10 Screening Market, By Region, 2020-2028 (USD Billion)       

11 Companion Diagnostics Market, By Region, 2020-2028 (USD Billion)         

12 Biometrics Market, By Region, 2020-2028 (USD Billion)     

13 Other Diagnostics Market, By Region, 2020-2028 (USD Billion)     

14 Global Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)

15 NGS Pre-Sequencing Market, By Region, 2020-2028 (USD Billion)

16 NGS Sequencing Market, By Region, 2020-2028 (USD Billion)          

17 NGS Data Analysis Market, By Region, 2020-2028 (USD Billion)      

18 Regional Analysis, 2020-2028 (USD Billion)

19 North America Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)

20 North America Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)

21 North America Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)

22 North America Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)

23 North America Clinical Oncology Next Generation Sequencing Market, By Country, 2020-2028 (USD Billion)

24 U.S Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)

25 U.S Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)

26 U.S Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)

27 U.S Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)

28 Canada Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)

29 Canada Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)

30 Canada Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)

31 CANADA Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)

32 Mexico Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)

33 Mexico Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)

34 Mexico Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)

35 mexico Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)

36 Europe Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)

37 Europe Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)

38 Europe Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)

39 europe Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)

40 Germany Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)

41 Germany Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)

42 Germany Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)

43 germany Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)

44 UK Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)

45 UK Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)

46 UK Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)

47 U.k Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)

48 France Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)

49 France Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)

50 France Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)

51 france Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)

52 Italy Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)

53 Italy Clinical Oncology Next Generation Sequencing Market, By T End User Type, 2020-2028 (USD Billion)

54 Italy Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)

55 italy Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)

56 Spain Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)

57 Spain Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)

58 Spain Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)

59 spain Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)

60 Rest Of Europe Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)

61 Rest Of Europe Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)

62 Rest of Europe Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)

63 REST OF EUROPE Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)

64 Asia Pacific Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)

65 Asia Pacific Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)

66 Asia Pacific Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)

67 asia Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)

68 Asia Pacific Clinical Oncology Next Generation Sequencing Market, By Country, 2020-2028 (USD Billion)

69 China Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)

70 China Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)

71 China Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)

72 china Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)

73 India Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)

74 India Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)

75 India Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)

76 india Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)

77 Japan Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)

78 Japan Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)

79 Japan Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)

80 japan Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)

81 South Korea Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)

82 South Korea Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)

83 South Korea Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)

84 south korea Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)

85 Middle East and Africa Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)

86 Middle East and Africa Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)

87 Middle East and Africa Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)

88 MIDDLE EAST AND AFRICA Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)

89 Middle East and Africa Clinical Oncology Next Generation Sequencing Market, By Country, 2020-2028 (USD Billion)

90 Saudi Arabia Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)

91 Saudi Arabia Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)

92 Saudi Arabia Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)

93 saudi arabia Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)

94 UAE Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)

95 UAE Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)

96 UAE Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)

97 uae Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)

98 Central & South America Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)

99 Central & South America Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)

100 Central & South America Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)

101 CENTRAL & SOUTH AMERICA Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)

102 Central & South America Clinical Oncology Next Generation Sequencing Market, By Country, 2020-2028 (USD Billion)

103 Brazil Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)

104 Brazil Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)

105 Brazil Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)

106 brazil Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)

107 Illumina Inc.: Products & Services Offering

108 Thermo Fisher Scientific: Products & Services Offering 

109 F. Hoffmann-La Roche Ltd.: Products & Services Offering              

110 Agilent Technologies: Products & Services Offering        

111 Myriad Genetics: Products & Services Offering    

112 PERKIN ELMER: Products & Services Offering           

113 Caris Life Sciences: Products & Services Offering              

114 Eurofins Scientific: Products & Services Offering             

115 Qiagen, Inc: Products & Services Offering

116 Other Companies: Products & Services Offering  

LIST OF FIGURES

1 Global Clinical Oncology Next Generation Sequencing Market Overview

2 Global Clinical Oncology Next Generation Sequencing Market Value From 2020-2028 (USD Billion)

3 Global Clinical Oncology Next Generation Sequencing Market Share, By Technology Type (2022)

4 Global Clinical Oncology Next Generation Sequencing Market Share, By End User (2022)

5 Global Clinical Oncology Next Generation Sequencing Market Share, By Application Type (2022)

6 Global Clinical Oncology Next Generation Sequencing Market Share, By Workflow Type (2022)

7 Global Clinical Oncology Next Generation Sequencing Market, By Region (Asia Pacific Market)

8 Technological Trends In Global Clinical Oncology Next Generation Sequencing Market

9 Four Quadrant Competitor Positioning Matrix

10 Impact Of Macro & Micro Indicators On The Market

11 Impact Of Key Drivers On The Global Clinical Oncology Next Generation Sequencing Market

12 Impact Of Challenges On The Global Clinical Oncology Next Generation Sequencing Market

13 Porter’s Five Forces Analysis

14 Global Clinical Oncology Next Generation Sequencing Market: By Technology Type Scope Key Takeaways

15 Global Clinical Oncology Next Generation Sequencing Market, By Technology Type Segment: Revenue Growth Analysis

16 Whole Genome Sequencing Market, By Region, 2020-2028 (USD Billion) 

17 Whole Exome Sequencing Market, By Region, 2020-2028 (USD Billion)

18 Targeted Sequencing & Resequencing Market, By Region, 2020-2028 (USD Billion)

19 Global Clinical Oncology Next Generation Sequencing Market: By End User Scope Key Takeaways

20 Global Clinical Oncology Next Generation Sequencing Market, By End User Segment: Revenue Growth Analysis

21 Hospitals Market, By Region, 2020-2028 (USD Billion)

22 Clinics Market, By Region, 2020-2028 (USD Billion)

23 Laboratories Market, By Region, 2020-2028 (USD Billion)

24 Global Clinical Oncology Next Generation Sequencing Market: By Application Type Scope Key Takeaways

25 Global Clinical Oncology Next Generation Sequencing Market, By Application Type Segment: Revenue Growth Analysis

26 Screening Market, By Region, 2020-2028 (USD Billion)         

27 Companion Diagnostics Market, By Region, 2020-2028 (USD Billion)

28 Biometrics Market, By Region, 2020-2028 (USD Billion)         

29 Other Diagnostics Market, By Region, 2020-2028 (USD Billion)       

30 Global Clinical Oncology Next Generation Sequencing Market: By Workflow Type Scope Key Takeaways

31 Global Clinical Oncology Next Generation Sequencing Market, By Workflow Type Segment: Revenue Growth Analysis

32 NGS Pre-Sequencing Market, By Region, 2020-2028 (USD Billion) 

33 NGS Sequencing Market, By Region, 2020-2028 (USD Billion)        

34 NGS Data Analysis Market, By Region, 2020-2028 (USD Billion)

35 Regional Segment: Revenue Growth Analysis

36 Global Clinical Oncology Next Generation Sequencing Market: Regional Analysis

37 North America Clinical Oncology Next Generation Sequencing Market Overview

38 North America Clinical Oncology Next Generation Sequencing Market, By Technology Type

39 North America Clinical Oncology Next Generation Sequencing Market, By End User

40 North America Clinical Oncology Next Generation Sequencing Market, By Application Type

41 North America Clinical Oncology Next Generation Sequencing Market, By Workflow Type

42 North America Clinical Oncology Next Generation Sequencing Market, By Country

43 U.S. Clinical Oncology Next Generation Sequencing Market, By Technology Type

44 U.S. Clinical Oncology Next Generation Sequencing Market, By End User

45 U.S. Clinical Oncology Next Generation Sequencing Market, By Application Type

46 U.S. Clinical Oncology Next Generation Sequencing Market, By Workflow Type

47 Canada Clinical Oncology Next Generation Sequencing Market, By Technology Type

48 Canada Clinical Oncology Next Generation Sequencing Market, By End User

49 Canada Clinical Oncology Next Generation Sequencing Market, By Application Type

50 Canada Clinical Oncology Next Generation Sequencing Market, By Workflow Type

51 Mexico Clinical Oncology Next Generation Sequencing Market, By Technology Type

52 Mexico Clinical Oncology Next Generation Sequencing Market, By End User

53 Mexico Clinical Oncology Next Generation Sequencing Market, By Application Type

54 Mexico Clinical Oncology Next Generation Sequencing Market, By Workflow Type

55 Four Quadrant Positioning Matrix

56 Company Market Share Analysis

57 Illumina Inc.: Company Snapshot

58 Illumina Inc.: SWOT Analysis

59 Illumina Inc.: Geographic Presence

60 Thermo Fisher Scientific: Company Snapshot

61 Thermo Fisher Scientific: SWOT Analysis

62 Thermo Fisher Scientific: Geographic Presence

63 F. Hoffmann-La Roche Ltd.: Company Snapshot

64 F. Hoffmann-La Roche Ltd.: SWOT Analysis

65 F. Hoffmann-La Roche Ltd.: Geographic Presence

66 Agilent Technologies: Company Snapshot

67 Agilent Technologies: Swot Analysis

68 Agilent Technologies: Geographic Presence

69 Myriad Genetics: Company Snapshot

70 Myriad Genetics: SWOT Analysis

71 Myriad Genetics: Geographic Presence

72 Perkin Elmer: Company Snapshot

73 Perkin Elmer: SWOT Analysis

74 Perkin Elmer: Geographic Presence

75 Caris Life Sciences: Company Snapshot

76 Caris Life Sciences: SWOT Analysis

77 Caris Life Sciences: Geographic Presence

78 Eurofins Scientific: Company Snapshot

79 Eurofins Scientific: SWOT Analysis

80 Eurofins Scientific: Geographic Presence

81 Qiagen, Inc.: Company Snapshot

82 Qiagen, Inc.: SWOT Analysis

83 Qiagen, Inc.: Geographic Presence

84 Other Companies: Company Snapshot

85 Other Companies: SWOT Analysis

86 Other Companies: Geographic Presence

The Global Clinical Oncology Next Generation Sequencing Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

Clinical Oncology Next Generation Sequencing Market Size

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Clinical Oncology Next Generation Sequencing Market.

Clinical Oncology Next Generation Sequencing Market Growth

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Clinical Oncology Next Generation Sequencing Market Trends

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

Clinical Oncology Next Generation Sequencing Market Share

We value your investment and offer free customization with every report to fulfil your exact research needs.
This website is secure and your personal details are safe. Privacy
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The global clinical oncology next generation sequencing market is expected to grow at a CAGR of 16.4% from 2023 to 2028.
The key players operating in the market are Illumina Inc., Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Agilent Technologies, Myriad Genetics, Perkin Elmer, Caris Life Sciences, Partek, Inc., Eurofins Scientific and Qiagen N.V. among others.
Companies in the clinical oncology NGS market have promising growth prospects. Expanding precision oncology applications offer opportunities for novel platforms and liquid biopsy revenue. Adoption of personalized medicine creates demand for NGS-based diagnostics and therapies. Technological advancements drive innovation in cancer research and diagnosis.
The global clinical oncology NGS market growth is driven by technological advancements, rising healthcare spending, and increasing cancer prevalence. COVID-19 impacted the market through regulatory guidelines and expanded NGS test coverage. Rising precision oncology, viral genetic sequencing, and liquid biopsy adoption contributes to the market growth.

Tailor made solutions just for you

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

OUR CLIENTS

  • Client of Global Market Estimates - Fedex
  • Client of Global Market Estimates - Samsung
  • Client of Global Market Estimates - Siemens
  • Client of Global Market Estimates - Lonza
  • Client of Global Market Estimates - DuPont
  • Client of Global Market Estimates - Medtronic
  • Client of Global Market Estimates - Toray
  • Client of Global Market Estimates - Signify
  • Client of Global Market Estimates - Teledyne
  • Client of Global Market Estimates - Trelleborg
  • Client of Global Market Estimates - Kikkoman Biochemifa
  • Client of Global Market Estimates - Leoni
  • Client of Global Market Estimates - Molnlycke
  • Client of Global Market Estimates - Spirent
  • Client of Global Market Estimates - Tokyo Electron Limited
  • Client of Global Market Estimates - Aranca
  • Client of Global Market Estimates - Asahi Kasei
  • Client of Global Market Estimates - Chimai
  • Client of Global Market Estimates - Grapsud
  • Client of Global Market Estimates - Horiba
  • Client of Global Market Estimates - Indorama
  • Client of Global Market Estimates - L&T
  • Client of Global Market Estimates - Integralife
  • Client of Global Market Estimates - Synamedia
  • Client of Global Market Estimates - Sorrento Therapeutics
  • Client of Global Market Estimates - Solenis
  • Client of Global Market Estimates - Sartorius